Trending Now
Evofem Biosciences Inc (NASDAQ: EVFM) Recently Executed an Agreement With VitaCare...
Evofem Biosciences Inc (NASDAQ: EVFM) recently announced the execution of a partnership agreement with VitaCare prescription services. The agreement stipulates the parties’ collaboration to...
DIH Holding US, Inc. (DHAI): Pioneering Rehabilitation with Cutting-Edge Technology
Let’s talk about something truly inspiring: the future of rehabilitation. On December 23, 2024, DIH Holding US, Inc. (NASDAQ: DHAI) announced...
Predictive Oncology Inc. (Nasdaq: POAI): A Transformative Acquisition by Renovaro Inc.
The biotechnological domain is currently abuzz with developments surrounding the acquisition of Predictive Oncology Inc. (Nasdaq: POAI) by Renovaro Inc. (Nasdaq: RENB)....
Popular News
Moderna Inc.’s (NASDAQ: MRNA) COVID-19 Vaccine Booster Under EU Review
Moderna Inc.’s (NASDAQ: MRNA) COVID-19 vaccine booster shot is under review by the EU regarding the possibility of administration after six months of the...
MAKE IT MODERN
LATEST REVIEWS
Biora Therapeutics Inc (NASDAQ: BIOR) Announces Topline Results From The Study...
Biora Therapeutics Inc (NASDAQ: BIOR) has announced topline results from the recently finalized study PM-611: Safety and Functionality Assessment of the Drug Delivery System...
MAKE IT MODERN
PERFORMANCE TRAINING
Humanigen Inc (NASDAQ: HGEN) Announce Publication of Sub Analysis of Phase 3 LIVE-AIR Study...
Humanigen Inc (NASDAQ: HGEN) has announced a peer-reviewed publication of a sub-analysis of Phase 3 LIVE-AIR study of lenzilumab in Thorax. Thorax is the...
Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) Announce That The RELIEF TNX-102 SL Study In Fibromyalgia...
Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) has announced that its Phase 3 RELIEF study of TNX-102 SL met its primary endpoint. TNX-102 SL...
Agios Pharmaceutical (NASDAQ:AGIO) Withdrawals European MAA For TIBSOVO® In Treating Refractory/Relapsed IDH1-Mutant AML
Agios Pharmaceutical Inc. (NASDAQ:AGIO) has withdrawn its European Marketing Authorization Application (MAA) for TIBSOVO® in treating refractory or relapsed acute myeloid leukemia patients with...
Chromadex Corp (NASDAQ:CDXC) Collaborates With NIH-NIAID to Support the Study of Its Patent-Protected NR...
The virus that causes COVID-19 can live for several hours and up to three days either in the air or on surfaces. This is...
ISW Holdings Inc (OTCMKTS:ISWH) New Telehealth Business Just Got Good News
While telehealth is a powerful revolution according to basically everyone on the planet right now, and one that’s likely to be here and dominant...
MAKE IT MODERN
